Alligator Bioscience (Lund, Sweden) is an early-stage drug discovery and development company focusing on immunotherapy of cancer. Compared to conventional systemic immunotherapy, Alligator has pioneered a new treatment concept aiming at local administration. The treatment concept is expected to result in better efficacy and fewer adverse events compared to systemically administered immunotherapies. The most advanced compound, ADC-1013, is in pre-clinical development.
Alligator Bioscience AB